case_images: PMC10164376_01
case_images: Serum glucose and insulin dynamics over the time course of treatment with alpelisib, patient #1/. The x-axis, reflecting timeline is non-linear, black vertical lines indicate months. Periods under active alpelisib treatment are shaded gray. Medications affecting glycemic control are depicted chronologically (lower panel).
case_images: BTT-17-61-g0001.jpg
case_images: PMC10164376_01_BTT-17-61-g0001.jpg
case_images: f0001
case_images: Serum glucose and insulin dynamics over the time course of treatment with alpelisib are depicted in Figure 1, alongside a medication panel deploying chronologically administration of all agents affecting glycemic control.
case_images: PMC10164376_02
case_images: Serum glucose and insulin dynamics over the time course of treatment with alpelisib, patient #2. Periods under active alpelisib treatment are shaded gray. Medications affecting glycemic control are depicted chronologically (lower panel).
case_images: BTT-17-61-g0002.jpg
case_images: PMC10164376_02_BTT-17-61-g0002.jpg
case_images: f0002
case_images: Trajectories of glucose and insulin levels are depicted in Figure 2.
case_images: PMC10164376_03
case_images: PMC10164376_04